- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Michael Thorpy Discusses Comorbidity Burden in Patients With Chronic Insomnia
Michael Thorpy, MD, director, Sleep-Wake Disorders Center, Montefiore Medical Center, and professor of neurology, Albert Einstein College of Medicine, speaks on the common occurrence of other comorbidities in patients with chronic insomnia.
Patients with chronic insomnia often have other comorbid conditions pertaining to psychiatric or medical issues, as well as several other sleep disorders, said Michael Thorpy, MD, director, Sleep-Wake Disorders Center, Montefiore Medical Center, and professor of neurology, Albert Einstein College of Medicine.
Transcript
How can other comorbid sleep disorders exacerbate the effects of chronic insomnia?
Insomnia rarely occurs just by itself. Usually, there's something else that's going on. Often it may be a psychological, psychiatric problem, or a medical problem, but there are a number of other sleep disorders that can coexist with insomnia.
Obstructive sleep apnea syndrome is one that we're particularly concerned about these days because of the increased weight of the population. So, many people with insomnia have some sleep apnea.
It's usually when they have significant sleep apnea, they're more tired and fatigued, sleepy, and less complaining about nighttime sleep—unless they’re elderly. The elderly very often with their sleep apnea will tend to complain about nighttime sleep and have complaints of insomnia.
The Challenge of Addressing Drug Spend to Drive Down Total Cost of Care in EOM
October 27th 2024Stuart Staggs, vice president of transformation and shared services at McKesson, explained that oncology practices in the Enhancing Oncology Model (EOM) have a tough job driving down costs when drug costs make up a larger portion of the total cost of care.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Targeting Progression: Amivantamab’s Role in NSCLC After Osimertinib
October 24th 2024Amivantamab's role in non–small cell lung cancer (NSCLC) has been a highlight of the lung cancer space this year, with the 2 most recent approvals based on data from the MARIPOSA and MARIPOSA-2 trials.
Read More
